Treating Metabolic Acidosis for CKD Progression? Need for Higher Quality Data.
作者信息
Kilduff Stella, Brown Denver D, Melamed Michal L
机构信息
Division of Nephrology, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
出版信息
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):147-149. doi: 10.2215/CJN.0000000632. Epub 2024 Nov 20.
Abstract
摘要
相似文献
1
Treating Metabolic Acidosis for CKD Progression? Need for Higher Quality Data.
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):147-149. doi: 10.2215/CJN.0000000632. Epub 2024 Nov 20.
2
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Nephrol Dial Transplant. 2023 May 31;38(6):1448-1458. doi: 10.1093/ndt/gfac289.
3
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
J Am Soc Nephrol. 2024 Mar 1;35(3):311-320. doi: 10.1681/ASN.0000000000000292. Epub 2024 Jan 23.
4
Metabolic Acidosis in CKD: A Review of Recent Findings.
Kidney Med. 2021 Feb 10;3(2):267-277. doi: 10.1016/j.xkme.2020.12.006. eCollection 2021 Mar-Apr.
5
Correction of chronic metabolic acidosis for chronic kidney disease patients.
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001890. doi: 10.1002/14651858.CD001890.pub3.
6
Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.
Adv Chronic Kidney Dis. 2022 Jul;29(4):329-336. doi: 10.1053/j.ackd.2022.05.002.
7
Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
Kidney Int. 2017 Dec;92(6):1507-1514. doi: 10.1016/j.kint.2017.05.006. Epub 2017 Jul 18.
8
Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment.
Kidney Dis (Basel). 2021 Jun 4;7(6):452-467. doi: 10.1159/000516371. eCollection 2021 Nov.
9
Diagnosing metabolic acidosis in chronic kidney disease: importance of blood pH and serum anion gap.
Kidney Res Clin Pract. 2022 May;41(3):288-297. doi: 10.23876/j.krcp.21.200. Epub 2022 Jan 10.
10
Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
BMC Nephrol. 2021 May 19;22(1):185. doi: 10.1186/s12882-021-02385-z.
本文引用的文献
1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
J Am Soc Nephrol. 2024 Mar 1;35(3):311-320. doi: 10.1681/ASN.0000000000000292. Epub 2024 Jan 23.
3
Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
Lancet. 2023 Feb 18;401(10376):557-567. doi: 10.1016/S0140-6736(22)02606-X. Epub 2023 Jan 25.
4
Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over Time.
Kidney Med. 2022 Nov 17;5(1):100573. doi: 10.1016/j.xkme.2022.100573. eCollection 2023 Jan.
5
Low Serum Bicarbonate and CKD Progression in Children.
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):755-765. doi: 10.2215/CJN.07060619. Epub 2020 May 28.
6
Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
Am J Kidney Dis. 2020 Feb;75(2):225-234. doi: 10.1053/j.ajkd.2019.07.016. Epub 2019 Nov 5.
7
Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
J Nephrol. 2019 Dec;32(6):989-1001. doi: 10.1007/s40620-019-00656-5. Epub 2019 Oct 9.
8
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
Lancet. 2019 Apr 6;393(10179):1417-1427. doi: 10.1016/S0140-6736(18)32562-5. Epub 2019 Mar 8.
9
Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Kidney Int. 2014 Nov;86(5):1031-8. doi: 10.1038/ki.2014.83. Epub 2014 Apr 2.
10
Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3.
J Clin Invest. 1985 Aug;76(2):667-75. doi: 10.1172/JCI112020.
Zotero 插件